Annapolis Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Annapolis Financial Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-350	Closed	-$26K	–	546
2022 Q2	$26K	Hold	350	–	–	0.01%	223
2022 Q1	$28K	Hold	350	–	–	0.01%	233
2021 Q4	$28K	Hold	350	–	–	0.01%	238
2021 Q3	$27K	Hold	350	–	–	0.01%	219
2021 Q2	$28K	Hold	350	–	–	0.01%	201
2021 Q1	$28K	Hold	350	–	–	0.01%	188
2020 Q4	$25K	Buy	+350	New	+$23.4K	0.01%	190

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Annapolis Financial Services's PJP Position: Q3 2022 in Review

Annapolis Financial Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2022, closing a stake of 350 shares — an estimated $26K sold.

Annapolis Financial Services first reported a position in PJP in Q4 2020 and held it in 7 quarters. The position peaked at $28K in Q1 2022. 81 funds tracked by Wall St. Rank hold PJP as of Q3 2022.

Annapolis Financial Services reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Annapolis Financial Services sold 350 Invesco Pharmaceuticals ETF shares in Q3 2022, an estimated $26K.
Annapolis Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2020 and held it in 7 quarters.
Annapolis Financial Services's Invesco Pharmaceuticals ETF position peaked at $28K in Q1 2022.
81 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2022.

Based on Annapolis Financial Services's 13F filing for Q3 2022, filed 24 Oct 2022.